Effect of Sariva mool churna in Excessive Menstrual Bleeding

RANDOMISED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF SARIVA MOOL CHURNA IN THE MANAGEMENT OF ASRUGDAR W.S.R. TO ABNORMAL UTERINE BLEEDING. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112455

Enrollment

Registered

2026-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N92- Excessive, frequent and irregularmenstruation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient selected from age group 18 yrs to 50 yrs 2.Prolonged bleeding greater than 7 days 3.Quantitatively increase in menstrual bleeding .PBAC Score more than 100 4.Hb more than 7 gm /dl 5.Selection irrespective of marital status and parity

Exclusion criteria

Exclusion criteria: 1.Pregnant Women 2.Patient with post menopausal bleeding 3.Patient diagnosed with neoplasm 4.Patient with traumatic bleeding 5.Uterine and pelvic pathology like Fibroid(size more than 2 cm), polyp, Pelvic inflammatory disease,Tubo ovarian mass. 6.Any systemic disease like Diabetes mellitus, hypertension,Patient on anticoagulant therapy, HIV or VDRL or HbsAg positive patients. 7.Patient using any IUCD. 8.Patient with abortive bleeding. 9.Patient undergoing treatment for any other serious illness.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of sariva mool churna on amount of blood loss per vaginallyTimepoint: 3 month	—

Secondary

Measure	Time frame
To evaluate the effect of Sariva mool churna on Number of Per vaginal bleeding days. Associated symptoms like Angamard,Daurbalya,Bhrama.Timepoint: 3 month	—

Countries

India

Contacts

Public ContactDr Prashant Dalvi

M.A Podar Ayurvedic hospital,Mumbai

drdalvipn@gmail.com9822783636

Outcome results